Assistant Professor, University of Washington/Seattle Children's Hospital, Seattle, WA.
Associate Professor, Univeristy of Louisville, Luisiville, KY.
Semin Pediatr Neurol. 2021 Oct;39:100921. doi: 10.1016/j.spen.2021.100921. Epub 2021 Sep 3.
Epilepsy surgery has proven to be very effective in treating refractory focal epilepsies in children, producing seizure freedom or partial seizure control well beyond any other medical or dietary therapies. While surgery is mostly utilized in certain clinical phenotypes, either based on the location such as temporal lobe epilepsy, or based on the presence of known epileptogenic lesions such as focal cortical dysplasia, tumors or hemimegalencephaly, there is a growing body of evidence to support the role of surgery in other patients' cohorts that were classically not thought of as surgical candidates. These include patients with rare genetic disorders, electrical status epilepticus in sleep, status epilepticus and the very young patients. Furthermore, epilepsy surgery is not considered as a "last resort" as seizure and cognitive outcomes of surgery are considerably better when done earlier rather than later in relation to the time of onset of epilepsy and age of surgery especially in the context of known focal cortical dysplasia. This article examines the accumulating evidence of the utility of epilepsy surgery in these special circumstances.
癫痫手术已被证明对治疗儿童难治性局灶性癫痫非常有效,其产生的无癫痫发作或部分癫痫发作控制效果远远超过任何其他医学或饮食疗法。虽然手术主要用于某些临床表型,无论是基于位置(如颞叶癫痫),还是基于已知的致痫病变(如局灶性皮质发育不良、肿瘤或大脑半球巨脑畸形),但越来越多的证据支持手术在其他经典上不被认为是手术候选者的患者群体中的作用。这些患者包括患有罕见遗传疾病、睡眠中电持续状态癫痫、癫痫持续状态和非常年轻的患者。此外,癫痫手术并不被视为“最后的手段”,因为与癫痫发作开始时间和手术年龄相比,手术的癫痫发作和认知结果更早进行要好得多,特别是在已知局灶性皮质发育不良的情况下。本文研究了癫痫手术在这些特殊情况下的有效性的累积证据。